Early effects of anti-TNFα antibodies in horses with osteoarthritis.
Abstract: Osteoarthritis (OA) is the most common pathology in sport horses, presenting a chronic and recurrent course. Traditional anti-inflammatory treatments provide only temporary clinical improvement and pain relief; however, they have been associated with metabolic disorders in articular cartilage in the medium term. In this study, we generated a llama polyclonal antibody against equine TNF-α, which was used for intra-articular treatment in horses with OA. Treatment effects were assessed through clinical examination and the determination of inflammatory parameters (MMP-2, MMP-9, LDH, and GAGs) in synovial fluid prior to treatment (T0) and on day 30 (T30). Treated animals showed significant improvement in the clinical score, which decreased from 8.47 ± 2.57 to 6.16 ± 1.71 (mean ± SD) on T30 (p<0.001). Additionally, a reduction in the activity of MMP-2 (188% ± 82.99 to 147% ± 40.6%, p<0.05), MMP-9 (100% ± 61.28 to 74.37% ± 64.26, p<0.05), and LDH (239.3 IU/l ± 147.4 to 143 IU/l ± 61.21, p<0.01) was observed. Furthermore, on T30, GAGs levels were significantly increased (1.167 ± 0.46 mg/ml to 1.439 ± 0.267 mg/ml, p<0.01). These results indicate that the local blockade of pro-inflammatory molecules such as TNF-α reduces pain and the levels of inflammatory molecules associated with catabolic processes and joint damage.
Copyright © 2025. Published by Elsevier Inc.
Publication Date: 2025-02-14 PubMed ID: 39956345DOI: 10.1016/j.jevs.2025.105384Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
- Journal Article
Summary
This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.
This research investigated a new treatment for osteoarthritis in sport horses using antibodies targeting the inflammation marker TNF-α. The study found this treatment reduces pain and inflammation, presenting a potential improvement on traditional treatments.
Research background and methodology
- The study was conducted to examine a new method of treating osteoarthritis, a common condition in sport horses, which traditional treatments struggle to effectively manage without causing long-term damage.
- The researchers developed a polyclonal antibody from llamas targeted at an inflammation pathway in horses called TNF-α. This antibody was used to treat horses suffering from osteoarthritis.
- The effects of this treatment were assessed before the treatment (T0) and 30 days after the treatment (T30).
- The assessments included clinical examinations as well as analysis of inflammatory parameters such as MMP-2, MMP-9, LDH, and GAGs in the synovial fluid of the horses.
Research findings
- The horses treated with the antibodies showed significant improvement in their clinical scores after 30 days of treatment.
- The activity levels of MMP-2, MMP-9, and LDH, which are indicators of inflammation, were significantly reduced in the horses after treatment.
- On the other hand, the levels of GAGs, which are molecules associated with healthy cartilage and joints, were significantly increased after treatment.
Conclusion and implications
- These findings show that the anti-TNF-α antibody treatment significantly reduced pain and inflammatory markers in horses with osteoarthritis. This shows the potential effectiveness of this treatment in managing osteoarthritis, a commonly occurring problem in sport horses.
- Moreover, this new treatment seems to have a less damaging effect on joint health, which is common with traditional treatments. Therefore the anti-TNF-α antibody treatment might prove better over the long term.
- This research has implications for treatment of horses, particularly sport horses who often suffer from chronic osteoarthritis. It provides another important step in finding more effective and safe treatments for osteoarthritis in both animals and humans.
Cite This Article
APA
Perrone G, Giampaoli C, Smirnoff AL, Ochoa A, Pareja R, De Simone E.
(2025).
Early effects of anti-TNFα antibodies in horses with osteoarthritis.
J Equine Vet Sci, 105384.
https://doi.org/10.1016/j.jevs.2025.105384 Publication
Researcher Affiliations
- Chair of Equine Health and Production, Faculty of Veterinary Sciences, University of Buenos Aires, Av. Chorroarín 280 (C1427CWO), Buenos Aires, Argentina.
- Chair of Animal Physiology, Faculty of Veterinary Sciences, University of Buenos Aires, Av. Chorroarín 280 (C1427CWO), Buenos Aires, Argentina.
- Chair of Animal Physiology, Faculty of Veterinary Sciences, University of Buenos Aires, Av. Chorroarín 280 (C1427CWO), Buenos Aires, Argentina.
- Chair of Animal Physiology, Faculty of Veterinary Sciences, University of Buenos Aires, Av. Chorroarín 280 (C1427CWO), Buenos Aires, Argentina.
- Chair of Animal Physiology, Faculty of Veterinary Sciences, University of Buenos Aires, Av. Chorroarín 280 (C1427CWO), Buenos Aires, Argentina.
- Chair of Animal Physiology, Faculty of Veterinary Sciences, University of Buenos Aires, Av. Chorroarín 280 (C1427CWO), Buenos Aires, Argentina. Electronic address: edesimone@fvet.uba.ar.
Conflict of Interest Statement
Declaration of competing interest The authors participating in the preparation of this article declare that they have no conflicts of interest.
Citations
This article has been cited 0 times.Use Nutrition Calculator
Check if your horse's diet meets their nutrition requirements with our easy-to-use tool Check your horse's diet with our easy-to-use tool
Talk to a Nutritionist
Discuss your horse's feeding plan with our experts over a free phone consultation Discuss your horse's diet over a phone consultation
Submit Diet Evaluation
Get a customized feeding plan for your horse formulated by our equine nutritionists Get a custom feeding plan formulated by our nutritionists